CRVS has been granted a new patent
Dec 25, 2024, 11:36 PM
8.16%
What does CRVS do
Corvus Pharmaceuticals, a clinical-stage biopharmaceutical company based in Burlingame, California, develops immune modulators for cancers and autoimmune diseases, with key products including soquelitinib and ciforadenant. Founded in 2016, it employs 28 people and focuses on innovative immunotherapy approaches.
CRVS filed a patent for "methods for treating renal cell carcinoma" on Tue, December 27, 2022.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.